Immunaffect B.V. - Generation & optimization of anti-FCGR2B antibodies to create tolerizing vaccines for autoimmune diseases and severe allergy
The aim of the current project is to achieve Proof of Principle for the use of fully human agonistic antibodies targeted at the antibody binding receptor FCGR2B for use in...